Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
Vaccinia virus (VACV), the prototype poxvirus, encodes numerous proteins that modulate the host response to infection. Two such proteins, B14 and A52, act inside infected cells to inhibit activation of NF-kappaB, thereby blocking the production of pro-inflammatory cytokines. We have solved the cryst...
Автори: | Graham, S, Bahar, M, Cooray, S, Chen, R, Whalen, D, Abrescia, N, Alderton, D, Owens, R, Stuart, D, Smith, G, Grimes, J |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Public Library of Science
2008
|
Схожі ресурси
Схожі ресурси
-
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
за авторством: Stephen C Graham, та інші
Опубліковано: (2008-08-01) -
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB.
за авторством: Benfield, C, та інші
Опубліковано: (2011) -
Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
за авторством: Bahar Miraghazadeh, та інші
Опубліковано: (2018-04-01) -
NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
за авторством: Smith, C, та інші
Опубліковано: (2001) -
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
за авторством: Andreakos, E, та інші
Опубліковано: (2006)